Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

China flag China · Delayed Price · Currency is CNY
17.32
+0.01 (0.06%)
Jul 17, 2025, 2:45 PM CST
21.97%
Market Cap6.59B
Revenue (ttm)3.16B
Net Income (ttm)148.86M
Shares Out379.33M
EPS (ttm)0.39
PE Ratio44.52
Forward PEn/a
Dividend0.30 (1.73%)
Ex-Dividend DateMay 14, 2025
Volume20,298,428
Average Volume21,039,862
Open16.89
Previous Close17.31
Day's Range16.89 - 17.37
52-Week Range10.65 - 23.22
Beta0.56
RSI59.77
Earnings DateAug 21, 2025

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China. [Read more]

Industry Chemicals
Sector Materials
Founded 2004
Employees 3,657
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300233
Full Company Profile

Financial Performance

In 2024, SHE:300233's revenue was 3.37 billion, a decrease of -4.66% compared to the previous year's 3.54 billion. Earnings were 196.78 million, an increase of 12.63%.

Financial Statements

News

There is no news available yet.